Improving the lives of people living with cancer

Slides:



Advertisements
Similar presentations
Single Center Experience with Drug Eluting Stents for Infrapopliteal Occlusive Disease in Patients with Critical Limb Ischemia: Mid-term follow up Robert.
Advertisements

Neuroradiology Dr Mohamed El Safwany, MD. Intended Learning Outcomes  The student should be able to understand role of medical imaging in the evaluation.
Targeted Cancer Therapeutics, LLC Investor Presentation.
Gastric Artery Embolization with X-ray-visible Embolic Beads and C-arm Cone Beam CT for Increased Accuracy Clifford R. Weiss MD1, Paul DiCamillo MD PhD2,
Bariatric embolization: an interventional radiologic treatment for obesity Ben E. Paxton M.D., Aravind Arepally M.D., Charles Y. Kim, M.D. Charles Y. Kim,
Interventional Oncology Michael Kotton MD October 27, 2012.
Consent for Research Study A study for patients newly diagnosed with advanced glioblastoma (brain cancer): Learning whether a PET scan with F-fluoromisonidazole.
Consent for Research Study A Study for Women with Advanced Cervical Cancer: Learning whether an MRI scan with an investigative contrast agent (called.
Coronary Stent Megan French. What is a Stent A small, mesh-like device made of metal Acts as a support or scaffold, in keeping the vessel open Stent helps.
Therapeutic Peptides for Cardiovascular Disease and Cancer Cam Patterson, MD, MBA, FACC, FAHA Ernest and Hazel Craige Distinguished Professor of Cardiovascular.
Radiofrequency Ablation of Lung Cancer
First HAYAT Annual Patients Forum – 21 st March 2010 – SAS, Kuwait First HAYAT Annual Patients Forum 21 st March 2010 Al Hashimi II Ballroom – SAS Hotel.
Interventional Radiology in Cancer Patients C. Douglas Edmondson, M.D., FACR C. Douglas Edmondson, M.D., FACR Interventional and Diagnostic Radiologist.
ACRIN 6671/GOG 0233 Consent for Research Study A study for Women with Advanced Cervical Cancer: Learning whether a PET/CT scan using an imaging agent called.
Dr Richard J Owen – Interventional Radiology
Minimally-Invasive Management of Post-Caesarian Section Bleeding by Interventional Radiology Michael S. Stecker, MD, FSIR Raj Pyne, MD Chieh-Min Fan, MD.
Cardiac Catheters for Delivery of Cell Suspensions Donald Nick Jensen, DVM, MS Division of Cardiovascular Devices HHS/FDA/CDRH.
Consent for Research Study A study using 18 F-Fluoride for prostate cancer patients currently enrolled in Dr. Febbo’s “Genomic Guided Therapy” study A.
Consent for Research Study A study for patients newly diagnosed with advanced glioblastoma (brain cancer): Learning whether a PET scan with F-fluoromisonidazole.
Echo in the palm of your hand Anthony DeMaria, MD Chief of Cardiovascular Medicine University of California at San Diego San Diego, CA.
Photodynamic Therapy Daniel Simon, MD Director of the Molecular and Cellular Interventional Cardiology Research Laboratory Brigham and Women’s Hospital.
What is double circulation?
FDA’s Public Workshop: Innovative Systems for Delivery of Drugs and Biologics: Scientific, Clinical, and Regulatory Challenges Paul Goldfarb, MD, FACS.
Molecular Imaging & Positron Emission Tomography Nicholas Mulhern BME 281.
Improving Microcatheter Navigation Through the Brain Matt Kergosien Holly Bonar Advisor : Dr. Ted Larson.
March 24, 2004BME 272/2731 Investigation of Bubble Formation in Tuohy-Borst Adaptors Department of Biomedical Engineering Melanie Bernard, Isaac Clements,
Cauterizing Biopsy Catheter for Percutaneous and/or Vascular Intervention Charles Blyth Cristina Fernandez Scott Hittinger Cameron Jones Brian McGee.
February 4, 2004BME 272/2731 Investigation of Bubble Formation in Tuohy-Borst Adaptors Department of Biomedical Engineering Melanie Bernard, Isaac Clements,
21 CFR Toby A. Silverman, M.D. Branch Chief, Clinical Review Branch Division of Hematology, Office of Blood December 14, 2006.
ClearWay™ RX Therapeutic Perfusion Catheter. ClearWay™ RX In Action Potential Advantages of ClearWay TM: Delivers drug at high concentration to site of.
The SAFER Trial Evaluation of the Clinical Safety and Efficacy of the PercuSurge GuardWire in Saphenous Vein Graft Intervention As presented at TCT 2000.
Monday Case of the Day A) The treatment was successful: The bremsstrahlung SPECT (Fig 2) indicates that 90 Y was deposited in the tumor. B) The treatment.
Targeted Drug Therapeutics An overview of our technologies and their potential 505(b)(2) applications Sino-American Regulatory Consulting Alliance Yongtian.
Date of download: 6/2/2016 Copyright © The American College of Cardiology. All rights reserved. From: Retrograde Techniques and the Impact of Operator.
6 - 1 Introduction to US Health Care Chapter 6 Research and Technology.
Double lumen remodeling balloon: New technique for treatment of MCA bifurcation aneurysm Kadziolka K, Leautaud A., Estrade L., W. Mustafa, Pierot L. CHU.
MRI Liver Phantom for Transarterial Chemoembolization Simulation Team Leader – Benjamin Engel Communicator – Eric Printz BWIG – Ryan Carroll BSAC – Justin.
M ax D elbrück L ecture Date:June 17th, 2008 Speaker: Kenneth R. Chien MGH Cardiovascular Research Center Boston, USA Title:Toward human models of human.
January 26, 2004BME 272/2731 Investigation of Bubble Formation in Tuohy-Borst Adaptors Department of Biomedical Engineering Melanie Bernard, Isaac Clements,
Endovascular treatment of intra- and extra cranial malformation
The Endocross Enabler-P: First in-Human Results
DEBATE: Attenuation of IR Turf
FIGURE 1. Illustration of the retractable, self-expandable Enterprise stent (Cordis, Miami Lakes, FL). From: PRELIMINARY EXPERIENCE WITH THE ENTERPRISE.
cyberknife®: can we cure pancreatic cancer?
Transvenous AVM Embolization: is it a solution for AVM treatment?
Clinical Research Contribution towards improving Clinical Care
Abbott Vascular Bifurcation Program
Portal Vein Stenting for Metastatic Neuroendocrine Tumor
OneShot™ Renal Denervation System
New England Society of Interventional Radiology November 14, 2016
ClearWay™ RX Therapeutic Perfusion Catheter
A Novel “Stent-On-A-Wire”Ultra Low Profile Stent Delivery System
A Fixed Guidewire Stent Delivery System
Endovascular treatment of renal artery aneurysms and renal arteriovenous fistulas  Zhongming Zhang, MD, Min Yang, MD, Li Song, MD, Xiaoqiang Tong, MD,
Nikhil Amesur, MD, John S. Hammond, MD, Albert B. Zajko, MD, David A
What Are Clinical Trials?
Regulatory Considerations for Coronary Drug Coated Balloons – FDA View
Clinical Trials in STS Shreyaskumar Patel, M.D.
Advances in Interventional Cardiology
Investment Opportunity and
What is Interventional Radiology?
Presentation for CANN 340 B Commission Testimony
Percutaneous balloon fenestration and stenting for life-threatening ischemic complications in patients with acute aortic dissection  Suzanne M. Slonim,
Gray R. Lyons, MD, PhD, Bradley B. Pua, MD, FSIR 
Clinical and economic evaluation of the trellis thrombectomy device for arterial occlusions: preliminary analysis  Timur P. Sarac, MD, Daniel Hilleman,
Cyto-Care… specialized in cell collection.
Daniel S. Kassavin, MD, Daniel G. Clair, MD 
Endovascular treatment of renal artery aneurysms and renal arteriovenous fistulas  Zhongming Zhang, MD, Min Yang, MD, Li Song, MD, Xiaoqiang Tong, MD,
Endovascular treatment of an internal carotid artery thrombus using reversal of flow: A case report  Juan C. Parodi, MD, Brian G. Rubin, MD, Ali Azizzadeh,
A, Selective angiography of the left L2 lumbar artery shows prominent tumor vascularity. A, Selective angiography of the left L2 lumbar artery shows prominent.
Presentation transcript:

Improving the lives of people living with cancer

Superior Tracking and Pushability Improved Tumor Fill Reduced Non-Target Embolization Simple Integration Superior tracking and pushability Improved tumor fill Reduced Non-Target Embolization Simple integration

Superior Tracking & Pushability Photos courtesy of Aaron Fischman, MD

Problems to be Solved Embolization with a Standard Microcatheter Tumor Stomach Liver Intestine * Injection with Standard Catheter > High Pressure Flow towards healthy tissues Embolization with a Standard Microcatheter The drug/embolic agent is injected under high arterial pressure Drug/embolic agent delivery is random and not reproducible Does not optimally fill the tumor Travels to healthy tissue via antegrade and retrograde flow

Deliver embolic agents more confidently Low Pressure Embolization (LPE) LPE represents a paradigm shift in standard drug-delivery for tumor therapy. Deliver embolic agents more confidently and with more control. LPE represents a paradigm shift in standard drug-delivery for tumor therapy. Deliver embolic agents more confidently and with more control.

Low Pressure Embolization (LPE) * > Lower Flow redirection toward tumor Embolization with a Sniper Microcatheter The balloon occludes the artery resulting in low pressure near the tumor Branch arteries are redirected and flow toward the low pressure Drug/embolic agent flows exclusively into the tumor since it has the lowest pressure Drug reaches tumor vessels Drug does not flow toward healthy tissue

Improved Tumor Fill with LPE Sniper Microcatheter with Y90 Standard Microcatheter w/ Tc-99m MAA Post-procedure SPECT Scan Post-procedure SPECT Scan Infusion with a standard high flow microcatheter results in preferential Tc-99m MAA deposition along the periphery of the tumor. Infusion with an Embolx Sniper Microcathteter yields uniform distribution of Y90 throughout entire tumor. Photos courtesy of Brian Kouri, MD

Schedule a Clinical Demonstration. Speak to an Embolx Representive to Learn More. info@embolx.com 408.990.2949 Embolx, Inc | 740 San Aleso Ave | Sunnyvale, CA 94085

Improved Tumor Fill with LPE Standard Catheter Embosphere 100-300µ Embozene 400µ Embozene 250µ InfusionType Study concluded that 2.4 X the amount of embolic agents are collected with Sniper as compared to a standard catheter. NSF Funded Animal Study

Reduced Non-target Flow with LPE Sniper® Balloon Tumor Artery Only Tumor Artery is visible, all other arteries flow toward the tumor when the Sniper® balloon is inflated Only Tumor Artery is visible, all other arteries flow toward the tumor when the Sniper® balloon is inflated Pseudo-Tumor Low Pressure Zone Right Hepatic Arteries Left Hepatic Arteries Particle Collection Tumor Artery All arteries are visible NSF Funded study conducted by at UCSD by Dr. Steve Rose, Chief of Interventional Oncology, UCSD Medical Center

Simple Integration High performance with comparable pricing to standard microcatheters Compatible with 5Fr diagnostic/guide catheter Easy to use Requires no additional accessories High performance with comparable pricing to standard microcatheters Compatible with 5Fr diagnostic/guide catheter Easy to use Requires no additional accessories

What Experts are Saying: "Bottom line, fixed temporary occlusion balloons and dynamic anti-reflux devices for transarterial embolization of liver tumors appear to simultaneously improve both safety and efficacy.” Steven C. Rose, MD FSIR Director of Interventional Oncology University of California, San Diego, CA

What Experts are Saying: "Manipulating blood pressure and flow to improve the tumor-killing effects of embolization therapies is a promising new technique. Using an occlusion balloon catheter has the potential of not only improving outcomes, but also simplifying the treatment technique to make this option available to more patients and doctors." Daniel Sze, MD PhD | Professor, Interventional Radiology Stanford University Medical Center Daniel Sze, MD PhD | Professor, Interventional Radiology Stanford University Medical Center

Schedule a Clinical Demonstration. Speak to an Embolx Representive to Learn More. info@embolx.com 408.990.2949 Embolx, Inc | 740 San Aleso Ave | Sunnyvale, CA 94085